DIGITAL HEALTH
“ Only by seeing the whole picture of a person can an uncommon biomarker be dismissed as no cause for concern ”
MATT LAVIN VP / GM , LIFEOMIC
idea to take the output of the algorithm seriously , even if we don ’ t fully understand the algorithm .
“ I think it ’ s still true that we have traditional diagnostics where we use biomarkers as inputs into treatments when we don ’ t fully understand the mechanism that explains why the biomarker is an effective guide . We should use what works .”
As with traditional biomarkers , Lavin believes that healthcare professionals should be working to understand what causes it to work so well .
“ In our search for understanding , sometimes new biomarkers are found . When working to understand algorithms , we ’ ll likely discover new areas of research and a better understanding of the differences between people that have an impact on health .” healthcare-digital . com 75